Stay updated on Cenobamate Open-Label Extension Study Clinical Trial
Sign up to get notified when there's something new on the Cenobamate Open-Label Extension Study Clinical Trial page.

Latest updates to the Cenobamate Open-Label Extension Study Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study content, replacing the previous details and navigation and making the record inaccessible until the issue is resolved.SummaryDifference17%

- Check19 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous v3.6.6, indicating a software release or patch. This update does not modify the study details or other substantive content.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor page/template update. No study content or data were altered.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4, representing a minor update to the site’s revision history.SummaryDifference0.0%

- Check68 days agoChange DetectedThe footer now shows Revision: v3.6.4, replacing v3.6.3. This reflects a software update to the page.SummaryDifference0.0%

- Check97 days agoChange DetectedBulgarian study locations have been updated, with new cities added and existing sites removed or adjusted, including Veliko Tarnovo, Varna, Sofia, and Blagoevgrad. The recruitment status now shows completion and no longer enrolling by invitation.SummaryDifference1%

Stay in the know with updates to Cenobamate Open-Label Extension Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cenobamate Open-Label Extension Study Clinical Trial page.